Orchestra BioMed Holdings, Inc. - OBIO
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 25, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
| Nov 19, 2025 | SCHEDULE 13G | Tasso Partners, LLC | 5.0% | 2,849,592 | View |
| Nov 19, 2025 | SCHEDULE 13G | Dana Lorenzo | 5.5% | 3,098,592 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Perceptive Advisors LLC | 9.99% | 5,679,480 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Joseph Edelman | 9.99% | 5,679,480 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 5,679,480 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.